[Translation] An open-label, multicenter, single-arm, phase I study to evaluate the safety and pharmacokinetics of datuximab beta maintenance therapy in Chinese patients with high-risk neuroblastoma
在中国高危神经母细胞瘤患者中评估达妥昔单抗β维持治疗的安全性和药代动力学。
[Translation] To evaluate the safety and pharmacokinetics of datuximab beta maintenance therapy in Chinese patients with high-risk neuroblastoma.